Back to
TWO SIGMA INVESTMENTS, LP
IBO5 quarters
Position history for
TWO SIGMA INVESTMENTS, LP's holdings in IMPACT BIOMEDICAL INC
Yes. Two Sigma holds 17,191 shares of IBO (Impact Biomedical), worth $7,908, as of its Q2 2026 13F filing. It reduced the position by 20,236 shares (-54.1%) from Q1 2026. Two Sigma has held IBO since Q2 2025, across 5 quarterly 13F filings.
Current Value
$7,908
Current Shares
17,191
Total Value Change
-$6,783
Total Shares Change
-5,509
Quarter-by-Quarter History
Other major holders of IBO: GEODE CAPITAL MANAGEMENT, LLC, VANGUARD CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC